| Baseline characteristic . | No. (%) . |
|---|---|
| Media age, years (range) | 69.0 (54-77) |
| Male/female | 12/8 |
| ECOG performance status 0/1 | 10/10 |
| Primary lesion | |
| Bladder | 8 (40) |
| Ureter | 7 (35) |
| Renal pelvis | 5 (25) |
| Metastatic sites | |
| Lymph node | 13 (65) |
| Lung | 8 (40) |
| Liver | 2 (10) |
| Pleura | 1 (5) |
| Peritoneal | 1 (5) |
| Renal | 1 (5) |
| None | 1 (5) |
| Other | 7 (35) |
| PD-L1 expression status | |
| Positive | 2 (10) |
| Negative | 7 (35) |
| Unknown | 11 (55) |
| Anemia | |
| Yes | 6 (30.0) |
| No | 14 (70.0) |
| Baseline characteristic . | No. (%) . |
|---|---|
| Media age, years (range) | 69.0 (54-77) |
| Male/female | 12/8 |
| ECOG performance status 0/1 | 10/10 |
| Primary lesion | |
| Bladder | 8 (40) |
| Ureter | 7 (35) |
| Renal pelvis | 5 (25) |
| Metastatic sites | |
| Lymph node | 13 (65) |
| Lung | 8 (40) |
| Liver | 2 (10) |
| Pleura | 1 (5) |
| Peritoneal | 1 (5) |
| Renal | 1 (5) |
| None | 1 (5) |
| Other | 7 (35) |
| PD-L1 expression status | |
| Positive | 2 (10) |
| Negative | 7 (35) |
| Unknown | 11 (55) |
| Anemia | |
| Yes | 6 (30.0) |
| No | 14 (70.0) |
| Baseline characteristic . | No. (%) . |
|---|---|
| Media age, years (range) | 69.0 (54-77) |
| Male/female | 12/8 |
| ECOG performance status 0/1 | 10/10 |
| Primary lesion | |
| Bladder | 8 (40) |
| Ureter | 7 (35) |
| Renal pelvis | 5 (25) |
| Metastatic sites | |
| Lymph node | 13 (65) |
| Lung | 8 (40) |
| Liver | 2 (10) |
| Pleura | 1 (5) |
| Peritoneal | 1 (5) |
| Renal | 1 (5) |
| None | 1 (5) |
| Other | 7 (35) |
| PD-L1 expression status | |
| Positive | 2 (10) |
| Negative | 7 (35) |
| Unknown | 11 (55) |
| Anemia | |
| Yes | 6 (30.0) |
| No | 14 (70.0) |
| Baseline characteristic . | No. (%) . |
|---|---|
| Media age, years (range) | 69.0 (54-77) |
| Male/female | 12/8 |
| ECOG performance status 0/1 | 10/10 |
| Primary lesion | |
| Bladder | 8 (40) |
| Ureter | 7 (35) |
| Renal pelvis | 5 (25) |
| Metastatic sites | |
| Lymph node | 13 (65) |
| Lung | 8 (40) |
| Liver | 2 (10) |
| Pleura | 1 (5) |
| Peritoneal | 1 (5) |
| Renal | 1 (5) |
| None | 1 (5) |
| Other | 7 (35) |
| PD-L1 expression status | |
| Positive | 2 (10) |
| Negative | 7 (35) |
| Unknown | 11 (55) |
| Anemia | |
| Yes | 6 (30.0) |
| No | 14 (70.0) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
